Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internatio...
Eyebright Medical has established its Asia-Pacific headquarters in Singapore, with the regional market becoming increasingly important for the group's growth | Lianhe Zaobao
30 public funds participated in the fixed increase, and 23 achieved full floating profits on the projects
Eyebright Medical: The Focus Deep Extended Artificial Lens has been approved for market launch through the Innovative Medical Device Special Review Procedure
Eyebright Medical: The company has not yet applied the materials of its main business products in the field of robotics
Eyebright Medical: Shareholder reduced holdings by 1.9972%
Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoon